CHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical Development
April 30, 2024 07:00 ET
|
Charm Therapeutics
PRESS RELEASE CHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical Development LONDON – 30 April 2024 -- CHARM Therapeutics (“CHARM”, “The Company”),...
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
March 19, 2024 10:00 ET
|
Charm Therapeutics
PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company...
CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability
January 04, 2023 07:00 ET
|
Charm Therapeutics
PRESS RELEASE CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability Enhanced leadership team brings strong AI and drug discovery...